Skip to main content
Mukka Proteins Limited logo

Mukka Proteins Limited — Investor Relations & Filings

Ticker · MUKKA ISIN · INE0CG401037 LEI · 3358001F6BWKSFSZ2U02 BSE.NS Manufacturing
Open in API
Filings indexed 220 across all filing types
Latest filing 2025-03-25 Capital/Financing Update
Country IN India
Listing BSE.NS MUKKA

About Mukka Proteins Limited

https://mukkaproteins.com/

Mukka Proteins Limited specializes in the manufacture and supply of high-quality fish meal, fish oil, and fish soluble paste. The company serves as a critical supplier to the global aquafeed, poultry feed, and pet food sectors. Its core operations involve processing raw fish into nutrient-dense protein sources and essential fatty acids, including Omega-3. The product portfolio includes steam-dried fish meal and high-grade fish oil used in specialized animal nutrition formulations. Mukka Proteins maintains a robust supply chain and utilizes advanced processing technologies to ensure product consistency and nutritional integrity. The company caters to both domestic and international markets, positioning itself as a key provider of sustainable marine protein ingredients for the livestock and aquaculture sectors.

Recent filings

Filing Released Lang Actions
Acquisition
Capital/Financing Update Classification · 95% confidence The document is an intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing about the Board of Directors' approval to make a strategic investment by acquiring a 51% stake in GSM Marine Export. It includes details about the acquisition such as the amount, nature of the transaction, background of the target entity, and other disclosures required under Schedule III of the Listing Regulations. There are no financial statements or detailed financial performance reports, nor is this a report or presentation. It is an announcement of a capital investment transaction. Therefore, this fits the category of Capital/Financing Update (CAP). The document length is 4377 characters, which is consistent with an announcement rather than a full report.
2025-03-25 English
Acquisition
Capital/Financing Update Classification · 95% confidence The document is an intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing about the Board of Directors' approval to make a strategic investment in another company. It includes details about the acquisition such as the target entity, consideration, shareholding percentage, and background information. There are no financial statements or comprehensive financial performance data presented. The document is a regulatory announcement about a capital investment transaction rather than a full financial report or earnings release. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is about 4987 characters, which is consistent with a detailed announcement but not a full report.
2025-03-25 English
Giving guarantees/indemnity/ becoming a surety for third party
Capital/Financing Update Classification · 95% confidence The document is an intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing the stock exchanges about the Board of Directors' approval for issuance of a corporate guarantee. It includes details about the guarantee, the related party interest, and the impact on the company. This is a regulatory announcement about a corporate action (issuance of corporate guarantee) rather than a financial report or detailed management discussion. The document length is about 3,070 characters, which is relatively short and focused on disclosure of a specific event. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to financing activities and corporate guarantees affecting the company's capital structure or contingent liabilities.
2025-03-25 English
Awarding of order(s)/contract(s)
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the receipt of purchase orders by Mukka Proteins Limited. It details the purchase orders received, their values, and related disclosures as per SEBI circular requirements. There is no financial report, earnings data, or management discussion. The document is a regulatory announcement about business updates, specifically purchase orders, which fits under general regulatory announcements and compliance disclosures. It does not fit into categories like Annual Report, Earnings Release, or Capital/Financing Update. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2025-03-05 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges in India, dated 16-02-2025, referencing compliance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It encloses copies of newspaper advertisements of unaudited financial results (standalone and consolidated) for the quarter and nine months ended 31st December 2024, published in newspapers on the same date. The document primarily serves as a notification of the publication of financial results in newspapers, rather than containing the financial results themselves or detailed financial statements. It is a regulatory compliance announcement about the advertisement of financial results, not the financial report itself. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance document.
2025-02-16 English
Monitoring Agency Report
Regulatory Filings Classification · 95% confidence The document is a Monitoring Agency Report related to the utilization of proceeds from an Initial Public Offering (IPO) for the quarter ended December 31, 2024. It references compliance with SEBI regulations concerning IPO proceeds monitoring. The report is prepared by ICRA Limited, the appointed Monitoring Agency, and includes detailed information on the use of IPO funds, deviations from the objects of the issue, certifications, and comments from the Board of Directors and the Monitoring Agency. This type of report is a regulatory requirement to ensure transparency in the use of IPO proceeds but is not a full annual or quarterly financial report, nor is it an earnings release or management discussion. It is a specialized report focused on IPO proceeds utilization, which fits the category of Regulatory Filings (RNS) as it is a compliance document and does not constitute a full financial report or audit report. The document length (15,000 characters) and detailed content confirm it is the report itself, not just an announcement of a report publication.
2025-02-14 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.